drugset / Trial / NCT03748173
Infasurf®(Calfactant) Aerosol for Infants With Bronchiolitis-AERO-04
RandomizedParallel-groupOpen-labelTreatment
Summary
Delivery of aerosolized Infasurf to bronchiolitis patients with who are not on assisted ventilation can provide sufficient delivery of Infasurf to small airways to improve ventilation and thereby shorten the duration of the respiratory illness.
Timeline
- Start
- 2019-01-12
- Primary completion
- 2020-10-02
- Completion
- 2020-10-21
Outcome
Outcome not reported
Stopped: “slowdown due to covid”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calfactant | Protein / enzyme biologic | 6 unknown | Inhaled |